The Pharmacology of Imepitoin: The First Partial Benzodiazepine Receptor Agonist Developed for the Treatment of Epilepsy

@article{Rundfeldt2013ThePO,
  title={The Pharmacology of Imepitoin: The First Partial Benzodiazepine Receptor Agonist Developed for the Treatment of Epilepsy},
  author={C. Rundfeldt and W. L{\"o}scher},
  journal={CNS Drugs},
  year={2013},
  volume={28},
  pages={29-43}
}
  • C. Rundfeldt, W. Löscher
  • Published 2013
  • Medicine
  • CNS Drugs
  • Although benzodiazepines (BZDs) offer a wide spectrum of antiepileptic activity against diverse types of epileptic seizures, their use in the treatment of epilepsy is limited because of adverse effects, loss of efficacy (tolerance), and development of physical and psychological dependence. BZDs act as positive allosteric modulators of the inhibitory neurotransmitter GABA by binding to the BZD recognition site (“BZD receptor”) of the GABAA receptor. Traditional BZDs such as diazepam or… CONTINUE READING
    53 Citations
    Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models
    • 7
    • PDF
    Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor
    • 4
    • PDF
    Imepitoin Shows Benzodiazepine-Like Effects in Models of Anxiety
    • 7
    • PDF
    GABA Receptors: Pharmacological Potential and Pitfalls.
    • 41
    • PDF

    References

    SHOWING 1-10 OF 69 REFERENCES
    Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders.
    • 41
    Partial agonists of the benzodiazepine receptor: from animal data to results in patients.
    • W. Haefely
    • Chemistry, Medicine
    • Advances in biochemical psychopharmacology
    • 1988
    • 40
    Novel anxiolytics that act as partial agonists at benzodiazepine receptors.
    • 219
    The novel anxiolytic ELB139 displays selectivity to recombinant GABAA receptors different from diazepam
    • 27
    Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABAA Receptor Modulators?
    • 116
    • PDF
    Anxioselective anxiolytics: on a quest for the Holy Grail.
    • P. Skolnick
    • Medicine
    • Trends in pharmacological sciences
    • 2012
    • 57
    • Highly Influential